WO1999058562A3 - Nouveaux composes - Google Patents
Nouveaux composes Download PDFInfo
- Publication number
- WO1999058562A3 WO1999058562A3 PCT/EP1999/003262 EP9903262W WO9958562A3 WO 1999058562 A3 WO1999058562 A3 WO 1999058562A3 EP 9903262 W EP9903262 W EP 9903262W WO 9958562 A3 WO9958562 A3 WO 9958562A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- novel compounds
- polypeptides
- basb009
- prophylactic
- diagnostic
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU42601/99A AU4260199A (en) | 1998-05-12 | 1999-05-10 | Novel compounds |
EP99950345A EP1086127A1 (fr) | 1998-05-12 | 1999-05-10 | Nouveaux composes |
CA002328061A CA2328061A1 (fr) | 1998-05-12 | 1999-05-10 | Nouveaux composes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9810193.4A GB9810193D0 (en) | 1998-05-12 | 1998-05-12 | Novel compounds |
GB9810193.4 | 1998-05-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999058562A2 WO1999058562A2 (fr) | 1999-11-18 |
WO1999058562A3 true WO1999058562A3 (fr) | 2001-05-17 |
Family
ID=10831938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1999/003262 WO1999058562A2 (fr) | 1998-05-12 | 1999-05-10 | Nouveaux composes |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1086127A1 (fr) |
AU (1) | AU4260199A (fr) |
CA (1) | CA2328061A1 (fr) |
GB (1) | GB9810193D0 (fr) |
WO (1) | WO1999058562A2 (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2571710A1 (fr) | 2004-06-24 | 2006-11-02 | Nicholas Valiante | Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence |
WO2006002422A2 (fr) | 2004-06-24 | 2006-01-05 | Novartis Vaccines And Diagnostics Inc. | Composes utilises pour l'immunopotentialisation |
WO2007047749A1 (fr) | 2005-10-18 | 2007-04-26 | Novartis Vaccines And Diagnostics Inc. | Immunisations mucosiques et systemiques avec particules de replicon d’alphavirus |
CA2630220C (fr) | 2005-11-22 | 2020-10-13 | Doris Coit | Antigenes de norovirus et de sapovirus |
CA2637598A1 (fr) | 2006-01-18 | 2007-02-14 | University Of Chicago | Compositions et procedes se rapportant a des proteines de bacteries staphylococciques |
EP2010537B1 (fr) | 2006-03-23 | 2011-12-28 | Novartis AG | Composés d'imidazoquinoxaline utilisés en tant qu'immunomodulateurs |
GB0713880D0 (en) | 2007-07-17 | 2007-08-29 | Novartis Ag | Conjugate purification |
CN101969992B (zh) | 2007-09-12 | 2014-10-01 | 诺华股份有限公司 | Gas57突变型抗原和gas57抗体 |
NZ586430A (en) | 2007-12-21 | 2012-09-28 | Novartis Ag | Mutant forms of streptolysin o (slo) |
CN102015651B (zh) | 2008-03-03 | 2014-12-31 | Irm责任有限公司 | 作为tlr活性调节剂的化合物和组合物 |
CN102481349B (zh) | 2009-01-12 | 2014-10-15 | 诺华股份有限公司 | 抗革兰氏阳性细菌疫苗中的Cna_B结构域 |
CA2765112A1 (fr) | 2009-06-10 | 2010-12-16 | Novartis Ag | Vaccins contenant de la benzonaphtyridine |
ES2596653T3 (es) | 2009-06-16 | 2017-01-11 | Glaxosmithkline Biologicals Sa | Ensayos bactericidas de opsonización y dependientes de anticuerpo mediado por el complemento de alto rendimiento |
JO3257B1 (ar) | 2009-09-02 | 2018-09-16 | Novartis Ag | مركبات وتركيبات كمعدلات لفاعلية tlr |
MX2012002723A (es) | 2009-09-02 | 2012-04-11 | Novartis Ag | Composiciones inmunogenicas que incluyen moduladores de la actividad de receptores tipo toll. |
WO2011057148A1 (fr) | 2009-11-05 | 2011-05-12 | Irm Llc | Composés et compositions permettant de moduler l'activité des tlr-7 |
CN102762206A (zh) | 2009-12-15 | 2012-10-31 | 诺华有限公司 | 免疫增强化合物的均匀悬液及其用途 |
KR101853513B1 (ko) | 2010-03-23 | 2018-04-30 | 노파르티스 아게 | 감염, 염증, 호흡기 질환 등의 치료를 위해 사용되는 tlr2 효능제로서의 화합물 (시스테인 기재 리포펩티드) 및 조성물 |
WO2011149564A1 (fr) | 2010-05-28 | 2011-12-01 | Tetris Online, Inc. | Infrastructure de jeu informatique asynchrone hybride interactif |
US9192661B2 (en) | 2010-07-06 | 2015-11-24 | Novartis Ag | Delivery of self-replicating RNA using biodegradable polymer particles |
WO2014118305A1 (fr) | 2013-02-01 | 2014-08-07 | Novartis Ag | Administration intradermique de compositions immunologiques comprenant des agonistes des récepteurs de type toll |
MX2020008417A (es) | 2018-02-12 | 2020-11-11 | Inimmune Corp | Ligandos de receptores de tipo toll. |
KR20230098825A (ko) | 2020-11-04 | 2023-07-04 | 엘리고 바이오사이언스 | 씨. 아크네스 개체군에게 dna 페이로드의 원위치 전달을 위한 파지-유래 입자 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995009025A1 (fr) * | 1993-09-29 | 1995-04-06 | The Research Foundation Of State University Of New York | VACCIN CONTRE $i(BRANHAMELLA CATARRHALIS) |
WO1995031215A1 (fr) * | 1994-05-17 | 1995-11-23 | The Research Foundation Of State University Of New York | VACCIN CONTRE $i(MORAXELLA CATARRHALIS) |
WO1997041731A1 (fr) * | 1996-05-03 | 1997-11-13 | Antex Biologics, Inc. | Polypeptide de la proteine-106 de la membrane externe de moraxella catarrhalis, sa sequence genetique et son utilisation |
WO1998006432A1 (fr) * | 1996-08-16 | 1998-02-19 | The Research Foundation Of State University Of New York | Proteine b1 de la membrane externe de moraxella catarrhalis |
-
1998
- 1998-05-12 GB GBGB9810193.4A patent/GB9810193D0/en not_active Ceased
-
1999
- 1999-05-10 WO PCT/EP1999/003262 patent/WO1999058562A2/fr not_active Application Discontinuation
- 1999-05-10 CA CA002328061A patent/CA2328061A1/fr not_active Abandoned
- 1999-05-10 EP EP99950345A patent/EP1086127A1/fr not_active Withdrawn
- 1999-05-10 AU AU42601/99A patent/AU4260199A/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995009025A1 (fr) * | 1993-09-29 | 1995-04-06 | The Research Foundation Of State University Of New York | VACCIN CONTRE $i(BRANHAMELLA CATARRHALIS) |
US5712118A (en) * | 1993-09-29 | 1998-01-27 | Research Foundation Of State University Of New York | Vaccine for branhamella catarrhalis |
WO1995031215A1 (fr) * | 1994-05-17 | 1995-11-23 | The Research Foundation Of State University Of New York | VACCIN CONTRE $i(MORAXELLA CATARRHALIS) |
US5607846A (en) * | 1994-05-17 | 1997-03-04 | Research Foundation Of State University Of New York | Vaccine for moraxella catarrhalis |
WO1997041731A1 (fr) * | 1996-05-03 | 1997-11-13 | Antex Biologics, Inc. | Polypeptide de la proteine-106 de la membrane externe de moraxella catarrhalis, sa sequence genetique et son utilisation |
WO1998006432A1 (fr) * | 1996-08-16 | 1998-02-19 | The Research Foundation Of State University Of New York | Proteine b1 de la membrane externe de moraxella catarrhalis |
Also Published As
Publication number | Publication date |
---|---|
GB9810193D0 (en) | 1998-07-08 |
WO1999058562A2 (fr) | 1999-11-18 |
EP1086127A1 (fr) | 2001-03-28 |
CA2328061A1 (fr) | 1999-11-18 |
AU4260199A (en) | 1999-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999058562A3 (fr) | Nouveaux composes | |
GB9810276D0 (en) | Novel compounds | |
WO1999055873A3 (fr) | Polynucleotide(s) et polypeptides basb006 isoles a partir de neisseria meningites | |
GB9820003D0 (en) | Novel compounds | |
AU3164600A (en) | Novel compounds | |
GB9809683D0 (en) | Novel compounds | |
AU4504999A (en) | Novel compounds | |
GB9810285D0 (en) | Novel compounds | |
GB9812440D0 (en) | Novel compounds | |
WO2002030971A3 (fr) | Nouveaux composes | |
AU4567300A (en) | Novel compounds | |
WO2002034768A3 (fr) | Nouveaux composes | |
EP2374889A3 (fr) | Nouveaux composés | |
GB9918208D0 (en) | Novel compounds | |
WO2002034772A3 (fr) | Nouveaux composes | |
GB0025170D0 (en) | Novel compounds | |
WO2003010195A3 (fr) | Nouveaux composes | |
AU6832300A (en) | Novel compounds | |
GB9918302D0 (en) | Novel compounds | |
WO2002030967A3 (fr) | Nouveaux composes | |
AU6568800A (en) | Novel compounds | |
WO1999058682A3 (fr) | Composes derives de moraxella catarrhalis | |
WO2002046215A3 (fr) | Nouveaux composes | |
AU6439700A (en) | Novel compounds | |
AU1383901A (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2328061 Country of ref document: CA Ref country code: CA Ref document number: 2328061 Kind code of ref document: A Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999950345 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1999950345 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09700335 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999950345 Country of ref document: EP |